Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

Jacobson, C. A., Chavez, J. C., Sehgal, A. R., William, B. M., Munoz, J., Salles, G., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Yakoub-Agha, I., Oluwole, O. O., Fung, H. C. H., Rosenblatt, J., Rossi, J. M., Goyal, L., Plaks, V., … Neelapu, S. S. (2022). Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. The Lancet Oncology, 23(1), 91–103. https://doi.org/10.1016/s1470-2045(21)00591-x
Authors:
Caron A. Jacobson
Julio C. Chavez
Alison R. Sehgal
Basem M. William
Javier Munoz
Gilles Salles
Pashna N. Munshi
Carla Casulo
David G. Maloney
Sven de Vos
Ran Reshef
Lori A. Leslie
Ibrahim Yakoub-Agha
Olalekan O. Oluwole
Henry Chi Hang Fung
Joseph Rosenblatt
John M. Rossi
Lovely Goyal
Vicki Plaks
Yin Yang
Remus Vezan
Mauro P. Avanzi
Sattva S. Neelapu
Affiliated Authors:
Ran Reshef
Publication Type:
Article
Unique ID:
10.1016/S1470-2045(21)00591-X
PMID:
Journal:
Publication Date:
Data Source:
Web of Science

Record Created: